熱門資訊> 正文
Entrada Therapeutics宣布注册直接发行1亿美元
2024-06-24 20:59
- Entrada Therapeutics (NASDAQ:TRDA) entered into a securities purchase agreement for the purchase of about 3.4M shares of common stock and pre-funded warrants to purchase up to 3.4M shares of common stock in a registered direct offering for gross proceeds of approximately $100 million.
- The purchase price for the common stock is $14.85 per share and the purchase price for the pre-funded warrants is $14.8499 per warrant.
- Source: Press Release
More on Entrada Therapeutics
- Entrada Therapeutics: A Complicated Tale
- Seeking Alpha’s Quant Rating on Entrada Therapeutics
- Historical earnings data for Entrada Therapeutics
- Financial information for Entrada Therapeutics
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
